GlaxoSmithKline Pakistan Limited (PSX:GLAXO)
320.08
-9.85 (-2.99%)
At close: Mar 27, 2026
GlaxoSmithKline Pakistan Market Cap
GlaxoSmithKline Pakistan has a market cap or net worth of 101.94 billion as of March 27, 2026. Its market cap has decreased by -18.57% in one year.
Market Cap
101.94B
Enterprise Value
95.30B
Revenue
62.07B
Ranking
n/a
PE Ratio
11.10
Stock Price
320.08
Market Cap Chart
Since September 26, 1994, GlaxoSmithKline Pakistan's market cap has increased from 3.77B to 101.94B, an increase of 2,603.24%. That is a compound annual growth rate of 11.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 101.94B | -17.88% |
| Dec 31, 2025 | 124.13B | -1.80% |
| Dec 31, 2024 | 126.40B | 378.26% |
| Dec 29, 2023 | 26.43B | -5.45% |
| Dec 30, 2022 | 27.95B | -35.70% |
| Dec 31, 2021 | 43.47B | -28.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott Laboratories (Pakistan) | 90.50B |
| AGP Limited | 50.40B |
| The Searle Company | 49.15B |
| Highnoon Laboratories | 45.99B |
| Citi Pharma | 16.65B |
| Ferozsons Laboratories | 14.37B |
| Macter International | 13.36B |
| Otsuka Pakistan | 3.75B |